
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Inhaled corticosteroids and the risk of fractures in children and adolescents”, Pediatrics, vol. 114, pp. 469-73, 2004.
, “Iron supplementation in Switzerland - A bi-national, descriptive and observational study”, Swiss Med Wkly, vol. 147, p. w14444, 2017.
, “Lifestyle factors, psychiatric and neurologic comorbidities, and drug use associated with incident seizures among adult patients with depression: a population-based nested case-control study”, Eur J Epidemiol, vol. 31, pp. 1113-1122, 2016.
, “Lithium, antipsychotics, and risk of psoriasis”, J Clin Psychopharmacol, vol. 29, pp. 134-40, 2009.
, “Long-term metformin use is associated with decreased risk of breast cancer”, Diabetes Care, vol. 33, pp. 1304-8, 2010.
, “Malaria chemoprophylaxis regimens: a descriptive drug utilization study”, Travel Med Infect Dis, vol. 12, pp. 718-25, 2014.
, “Metabolic syndrome in relation to risk of meningioma”, Oncotarget, vol. 8, pp. 2284-2292, 2017.
, “Metformin and the risk of endometrial cancer: a case-control analysis”, Gynecol Oncol, vol. 129, pp. 565-9, 2013.
, “Metformin and the risk of head and neck cancer: a case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 1148-54, 2014.
, “Metformin and the risk of renal cell carcinoma: a case-control analysis”, Eur J Cancer Prev, vol. 26, pp. 257-262, 2017.
, “Metformin does not alter the risk of lung cancer: a case-control analysis”, Lung Cancer, vol. 78, pp. 133-7, 2012.
, “Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study”, J Am Geriatr Soc, vol. 60, pp. 916-21, 2012.
, “Migraine and the risk of stroke, TIA, or death in the UK (CME)”, Headache, vol. 47, pp. 1374-84, 2007.
, “Migraine incidence, comorbidity and health resource utilization in the UK”, Cephalalgia, vol. 28, pp. 57-64, 2008.
, “Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom”, J Am Acad Dermatol, vol. 69, pp. 399-406, 2013.
, “Minocycline and lupuslike syndrome in acne patients”, Arch Intern Med, vol. 159, pp. 493-7, 1999.
, “No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study”, BMC Cancer, vol. 15, p. 719, 2015.
, “Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis”, Int J Cancer, vol. 137, pp. 2424-31, 2015.
, “Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer”, Int J Cancer, vol. 137, pp. 144-53, 2015.
, “NSAID use and risk of Parkinson disease: a population-based case-control study”, Eur J Neurol, vol. 18, pp. 1336-42, 2011.
, “Omeprazole, H2 blockers, and polyarthralgia: case-control study”, Bmj, vol. 315, p. 1283, 1997.
, “Omeprazole, other antiulcer drugs and newly diagnosed gout”, Br J Clin Pharmacol, vol. 44, pp. 175-8, 1997.
, “Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study”, Ann Med, vol. 47, pp. 492-8, 2015.
, “Parkinson disease and the risk of epileptic seizures”, Ann Neurol, vol. 83, pp. 363-374, 2018.
, “Parkinson's disease or Parkinson symptoms following seasonal influenza”, Influenza Other Respir Viruses, vol. 5, pp. 328-33, 2011.
, “Poorly controlled type 2 diabetes mellitus is associated with a decreased risk of incident gout: a population-based case-control study”, Ann Rheum Dis, vol. 74, pp. 1651-8, 2015.
, “A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease”, J Gastroenterol, vol. 51, pp. 1050-1062, 2016.
, “A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation”, N Engl J Med, vol. 339, pp. 719-24, 1998.
, “Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom”, Eur J Clin Microbiol Infect Dis, vol. 19, pp. 834-42, 2000.
, “Population-Based Study on the Epidemiology of Meniere's Disease”, Audiol Neurootol, vol. 22, pp. 74-82, 2017.
, “Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus”, J Rheumatol, vol. 25, pp. 1515-9, 1998.
, “The Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes Mellitus: A Case-Control Study”, PancreasPancreasPancreas, vol. 47, pp. 807-815, 2018.
, “Previously diagnosed influenza infections and the risk of developing epilepsy”, Epidemiol Infect, vol. 143, pp. 2408-15, 2015.
, “Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis”, Drug Saf, vol. 41, pp. 1387-1396, 2018.
, “Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis”, J Invest Dermatol, vol. 129, pp. 2604-12, 2009.
, “Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis”, Br J Dermatol, vol. 160, pp. 1048-56, 2009.
, “Psoriasis and the risk of incident diabetes mellitus: a population-based study”, Br J Dermatol, vol. 159, pp. 1331-7, 2008.
, “Reflux disease, gastrointestinal ulcer or weight loss in patients with COPD”, Copd, vol. 7, pp. 172-8, 2010.
, “Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study”, Ann Intern Med, vol. 152, pp. 78-84, 2010.
, “The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study”, Drug Saf, vol. 39, pp. 1229-1237, 2016.
, “Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations”, Climacteric, vol. 12, pp. 445-53, 2009.
, “Risk of cataract in patients treated with statins”, Arch Intern Med, vol. 161, pp. 2021-6, 2001.
, “Risk of colorectal cancer after initiation of orlistat: matched cohort study”, Bmj, vol. 347, p. f5039, 2013.
, “Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations”, Climacteric, vol. 12, pp. 514-24, 2009.
, “Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis”, Maturitas, vol. 132, pp. 17-23, 2020.
, “Risk of incident depression in patients with Parkinson disease in the UK”, Eur J Neurol, vol. 18, pp. 448-53, 2011.
, “Risk of Incident Osteoarthritis of the Hand in Statin Initiators: A Sequential Cohort Study”, Arthritis Care Res (Hoboken), vol. 70, pp. 1795-1805, 2018.
, “Risk of incident stroke in patients with Alzheimer disease or vascular dementia”, Neurology, vol. 81, pp. 910-9, 2013.
, “The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study”, J Gen Intern Med, 2021.
, “The risk of new onset depression in association with influenza–A population-based observational study”, Brain Behav Immun, vol. 53, pp. 131-137, 2016.
,